Diabetic Neuropathy Assessed with Multifrequency Vibrometry Develops Earlier than Nephropathy but Later than Retinopathy
Experimental and Clinical Endocrinology & Diabetes · 01.04.2023 · 131 (04) · 187-193
DOI: 10.1055/a-2010-6987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.04.2023. Verfasst von Eero Lindholm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Endocrinology, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Diabetic Nephropathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Swedish research Council, VINNOVA, Skåne University Hospital.
Abstract (Originalsprache)
Background
Diabetes is associated with systemic complications. Prevalence of diabetic nephropathy, and retinopathy, in type 1 diabetes mellitus (T1DM) is declining, but it is not known if this is true also for diabetic neuropathy.
Aim
To investigate the relationship between large fibre diabetic neuropathy and other diabetic complications. Materials and methods Neuropathy, defined here as large fibre neuropathy, was assessed by measuring vibration perception thresholds at four different frequencies on the sole of the foot, using a standard VibroSense Meter and/or neuropathic symptoms, in 599 individuals with T1DM. Retinopathy status was graded using the International Clinical Disease Severity Scale. Grade of albuminuria and previous history of any macrovascular complications were registered.
Results
Diabetic individuals without retinopathy had similar vibration thresholds as age- and gender-matched control participants without diabetes, whereas those without microalbuminuria had higher thresholds than controls. Two individuals out of 599 (0.3%) had microalbuminuria, but not retinopathy or neuropathy, and 12/134 (9%) without retinopathy had signs of neuropathy. Totally 119/536 (22%) of the patients without microalbuminuria had neuropathy. Vibration thresholds increased with the rising severity of retinopathy and grade of albuminuria. In a multinomial logistic regression analysis, neuropathy was associated with retinopathy (OR 2.96 [1.35–6.49], p=0.007), nephropathy (OR 6.25 [3.21–12.15]; p=6.7×10–8) and macrovascular disease (OR 2.72 [1.50–4.93], p=0.001).
Conclusions
Despite recent changes in the incidence of diabetic complications, the onset of large fibre neuropathy follows that of retinopathy but precedes the onset of nephropathy in T1DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Sciences, Endocrinology, Lund University, Malmö, Sweden.
- Department of Translational Medicine - Hand Surgery, Lund University, Malmö, Sweden.
- Department of Clinical Sciences, Neurology, Lund University, Malmö, Sweden.
- Department of Clinical Sciences, Endocrinology, Lund University, Lund, Sweden.
- Department of Hand Surgery, Skåne University Hospital, Malmö, Sweden.
Förderung
- Swedish research Council
- VINNOVA
- Skåne University Hospital
- Swedish Diabetes Foundation
Zitieren
APA
Lindholm, E., Ekman, L., Elgzyri, T., Lindholm, B., Löndahl, M., & Dahlin, L. (2023). Diabetic Neuropathy Assessed with Multifrequency Vibrometry Develops Earlier than Nephropathy but Later than Retinopathy. Experimental and Clinical Endocrinology & Diabetes, 131(04), 187-193. https://doi.org/10.1055/a-2010-6987
Vancouver
Lindholm E, Ekman L, Elgzyri T, Lindholm B, Löndahl M, Dahlin L. Diabetic Neuropathy Assessed with Multifrequency Vibrometry Develops Earlier than Nephropathy but Later than Retinopathy. Experimental and Clinical Endocrinology & Diabetes. 2023;131(04):187-193. doi:10.1055/a-2010-6987
BibTeX
@article{Lindholm2023,
author = {Lindholm, Eero and Ekman, Linnea and Elgzyri, Targ and Lindholm, Beata and Löndahl, Magnus and Dahlin, Lars},
title = {Diabetic Neuropathy Assessed with Multifrequency Vibrometry Develops Earlier than Nephropathy but Later than Retinopathy},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {04},
pages = {187--193},
doi = {10.1055/a-2010-6987}
}
EUVIMED